MedPath

A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions

Not Applicable
Recruiting
Conditions
Healthy
Financial Toxicity
Registration Number
NCT07042191
Lead Sponsor
Barbara Ann Karmanos Cancer Institute
Brief Summary

The overall goal of this research program is to address financial toxicity through the development, testing, and implementation of a multi-level communication intervention. If successful, this intervention could be a companion intervention for Cancer providers in combination with the already in testing DISCO app (Discussions of Cost App) for patients. Participants will:

* complete a baseline survey

* attend two one on one meetings, one as part of the development and the second as part of the pilot testing of the intervention.

Detailed Description

20 Wayne State University (WSU)/Karmanos Cancer Institute (KCI) oncology care providers (e.g., medical oncologists, nurses, social workers, APP) who treat patients at the KCI Detroit and Farmington Hills clinics where patients are treated for cancer will be recruited. At least two providers from each discipline who treat various cancer types will be included. The study will be discussed at clinic program meetings and then interested providers will be consented. Providers who consent will agree to 1) complete a baseline survey, and 2) attend two one-on-one meetings, one as a part of the DISCO (Discussion of Cost) Provider development (Aim 1) and the second as a part of the DISCO Provider pilot-testing (Aim 2).

To achieve Aim 1, participants will be asked to complete a survey eliciting their demographic and professional characteristics prior to interviews. Then, during one-on-one interviews, which will be audio recorded and subsequently transcribed, the investigators will present the DISCO Provider wireframes and ask participants to provide feedback on the planned content, organization, and implementation. The Investigators will also present participants with strategies identified from research on how to initiate, respond to, and effectively discuss cost concerns. Investigators will ask participants about ideas for website design and training intervention implementation. Participants will be asked to complete a needs assessment interview about their use of digital support tools.

To achieve Aim 2 and pilot test DISCO Provider, participants will again meet one-on-one with the Investigators. Investigators will ask participants to provide feedback on the acceptability and usability of the working version of DISCO Provider, whether participants think it is useful for training providers to discuss cost, if the strategies suggested will likely be effective, and suggestions for improvement. Meetings will be audio recorded, transcribed, and analyzed using similar methods as those in Aim 1

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Oncology care providers at Karmanos Cancer Institute (KCI)/Wayne State University(WSU) including medical oncologists, nurses, social workers and advance practice providers who treat cancer patients at KCI Detroit or Farmington Hills clinics
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Acceptability - Qualitative reportImmediately Post Pilot Test

Success of intervention measured by semi-structured qualitative interview method which addresses acceptability

Usability-Qualitative ReportImmediately post pilot test

Success of intervention measured by semi-structured qualitative interview method which addresses usability

Usefulness-Qualitative ReportImmediately Post Pilot Test

Success of intervention measured by semi-structured qualitative interview method which addresses usefulness

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Karmanos Cancer Institute

🇺🇸

Detroit, Michigan, United States

Karmanos Cancer Institute
🇺🇸Detroit, Michigan, United States
Lauren M Hamel, PhD
Principal Investigator
Susan Eggly, PhD
Sub Investigator
Eliza Beal, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.